⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Botanical Extracts for Sarcopenia
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-04 — Effects of Shanyu Pill in Older Adults With Sarcopenia: cross-connection with shanyu-pill: Shanyu Pill joins the botanical/TCM sarcopenia intervention landscape being formally tested in older adults. (novelty: 3)
- 2026-08-10 — HB05P on Muscle Health: cross-connection with akkermansia-muciniphila: HB05P pilot RCT places pasteurized Akkermansia alongside botanical and nutritional sarcopenia interventions as a postbiotic candidate for muscle strength in older adults. (novelty: 3)
- 2026-09-02 — Ursolic Acid-Standardized Apple Pomace Supplementation for Muscle Strength and Physical Performance in Older Adults With Mild Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Trial: cross-connection with ursolic-acid: Ursolic acid–standardized apple pomace joins the botanical-extract candidate set being tested for sarcopenia endpoints (handgrip, physical performance). (novelty: 3)
- 2026-06-25 — A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia: cross-connection with in-207907: Both target sarcopenia in older adults but from opposite ends of the pipeline — IN-207907 is an injectable clinical candidate in a dose-ranging RCT, whereas botanical extracts remain largely preclinical. (novelty: 3)
- 2026-04-02 — Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.: cross-connection with ginsenosides: Human trial evidence that Rg1 enhances muscle stem-cell and mitochondrial responses to resistance training situates ginsenosides within the botanical-extracts-for-sarcopenia landscape. (novelty: 3)
- 2026-07-28 — Bile salt hydrolase-active bifidobacterium animalis improves sarcopenia via the gut microbiota-bile acid-FXR-FGF15 axis and its functional fermented milk preparation.: cross-connection with bsh-active-bifidobacterium: Alternative non-pharmacological candidate acting on sarcopenia; the bile acid–FXR–FGF15 route is mechanistically distinct from botanical anti-atrophy pathways. (novelty: 3)
- 2026-08-01 — Diosgenin Alleviates Age-Related Sarcopenia by Promoting Satellite Cell Proliferation and Myogenic Differentiation via Activation of the SIRT1/PGC-1α Signaling Pathway.: cross-connection with diosgenin: Diosgenin joins the roster of plant-derived compounds with preclinical anti-sarcopenia signals, acting via SIRT1/PGC-1α rather than the mTOR/protein-synthesis axis emphasized by whey/HMB/creatine. (novelty: 3)
Open questions
Related
Contributing findings
Extracts Buffer Galactose-Induced Skeletal Muscle Sarcopenia in C2C12 Myotubes.
24-jul-2026
novelty 2
per-area 2
introduces